Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $163.6900 (0.81%) ($161.5100 - $164.2800) on Wed. Jan. 4, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.09% (three month average) | RSI | 60 | Latest Price | $163.6900(0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.1% a day on average for past five trading days. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) EDOC(10%) XBI(9%) MCHI(8%) FXI(7%) SHY(7%) | Factors Impacting ABBV price | ABBV will decline at least -0.545% in a week (0% probabilities). VIXM(-9%) IWN(-9%) JETS(-8%) IWM(-8%) IWC(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.545% (StdDev 1.09%) | Hourly BBV | 1.1 () | Intraday Trend | 0.8% | | | |
|
5 Day Moving Average | $162.56(0.7%) | 10 Day Moving Average | $162.56(0.7%) | 20 Day Moving Average | $162.67(0.63%) | To recent high | -1.4% | To recent low | 18.4% | Market Cap | $288.796b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |